BioStock: DanCann's CEO predicts a news-intensive spring

Report this content

Strengthened by a unique pilot project for medical cannabis in Denmark, and with the help of artificial intelligence and cultivation technology developed by NASA, DanCann Pharma was listed on Spotlight Denmark in November 2020. The listing was preceded by an IPO whose public share was subscribed to a total of 433 per cent, and which provided the company about 30 MDKK. BioStock reached out to CEO Jeppe Krog Rasmussen, who talks about the company’s activities since the listing and the plans for the company moving forward – it is clear that he expects a news-intensive first half of the year.

Read the full interview with Jeppe Krog Rasmussen at

This is a press release from BioStock - Connecting Innovation & Capital



Quick facts

BioStock: DanCann's CEO predicts a news-intensive spring
Tweet this